Andrew Hessel: Writing chromosomes with code
/Scientist Andrew Hessel explains the exciting possibilities of synthetic biology, including the potential to move from blockbuster drugs to a pipeline of personalized medicines. In so doing, he makes a case for his ambition to “genetically engineer everything in the world.” For more information, visit poptech.org.
Autodesk Distinguished Researcher Andrew Hessel is a catalyst in biological technologies, helping industry, academics, and authorities better understand the changes happening in life science. Andrew is a key member of the Bio/Nano/Programmable Matter group at Autodesk Research. He is also the co-founder of the Pink Army Cooperative, the world’s first cooperative biotechnology company, which is aiming to make open source viral therapies for cancer.

